Single-dose NEPA versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy.

Laurent Zelek Rudolph M Navari Matti Aapro Florian Scotte

Published in: Cancer medicine (2023)

A single dose of NEPA, administered on day 1 only, was more effective than a 3-day aprepitant regimen in preventing CINV for an extended duration in patients receiving MEC and in those with emetic risk factors.

Keyphrases

chemotherapy induced
risk factors
squamous cell carcinoma
radiation therapy
locally advanced
rectal cancer